Capstone Therapeutics's total assets for Q3 2024 were $51.53M, a decrease of -4.53% from the previous quarter. CAPS total liabilities were $53.46M for the fiscal quarter, a 102.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.